ARCHIVES

NIH Reauthorization Threatened By Fetal Research Issue

This article is from The Cancer Letter archive.

Vol. 16 No. 38 | October 5, 1990

Download PDF Visit The Full Archive

Related Articles

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990